Diabetes risk higher among some women who stay on antipsychotic while pregnant

Abstract

The Brown University Psychopharmacology UpdateVolume 29, Issue 9 p. 1-5 Antipsychotic Treatment Diabetes risk higher among some women who stay on antipsychotic while pregnant First published: 07 August 2018 https://doi.org/10.1002/pu.30349Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Abstract A study of pregnant women in a Medicaid database who were receiving an antipsychotic before pregnancy has found that those who continued treatment with olanzapine or quetiapine in early pregnancy had a higher risk of developing gestational diabetes than women who discontinued the medications during pregnancy. Risk of gestational diabetes was not found to be elevated with continued use of aripiprazole, ziprasidone, or risperidone in early pregnancy. Study results were published online May 7 in the American Journal of Psychiatry. Volume29, Issue9September 2018Pages 1-5 RelatedInformation